Britain’s regulator on Thursday said modified coronavirus vaccines meant to target highly transmissible variants can sidestep new approvals and extended clinical trials.
Modified COVID-19 vaccines targeting variants can skip lengthy trials, UK says
Britain’s regulator on Thursday said modified coronavirus vaccines meant to target highly transmissible variants can sidestep new approvals and extended clinical trials.